DISCOVER - NORDIC 

Background and Aims:
Previous research has shown similarities and differences between  type 2 diabetes (T2D) patients in general practice in the Nordic countries. The aim is to describe and compare patient populations, treatment modalities, complications and comorbidities in the Nordic countries, and follow the development over time.

Materials and Methods:
Electronic medical records (EMR) data on all T2D patients will be extracted once yearly from 60 primary care clinics in DK, NO and SE, and linked with national Prescribed Drug-, National Patient‐ and Cause of Death Registry data in the respective country.

The number of patients below targets was also greatest in DK compared to the other countries. Norway and Sweden demonstrated similar target patterns.

News from 2022:
No activity in the project this year, but plans for further analyses next year.

Primary Investigator: Kåre I. Birkeland

Co-investigators/participants:  
Kristian Furuseth, Solli Klinikk, Jessheim, Norway

External collaborators: 
Frederik Persson and Søren Tang Knudsen, Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Anders Lindh Åkersberga, Sweden
Peter M. Nilsson Lunds University, Lund, Sweden
Michael Alvarsson Karolinska University Hospital, Stockholm, Sweden
Marit Eika Jørgensen Steno Diabetes Center Copenhagen, Gentofte, Denmark
Jens Søndergaard University of Southern Denmark, Odense, Denmark
Marcus Thureson, Statisticon
Johan Bodegaard, Astra Zeneca
Susanna Jerström, Astra Zeneca